Rv0382c Orotate phosphoribosyltransferase (EC

Symbol Product Feature Type Start End Strand Length AA Length is TF
Rv0382c pyrE Orotate phosphoribosyltransferase (EC CDS 457841 458380 - 540 179 FALSE

Rv0382c (Orotate phosphoribosyltransferase (EC is predicted to be co-regulated in modules bicluster_0314 with residual 0.57 and bicluster_0315 with residual 0.53.

This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 0.00 and 0.00 for bicluster_0314 and 0.00 and 0.00 for bicluster_0315 respectively.

These modules are enriched for following go terms: .

This gene is found to be for growth on cholesterol.

Mutant available?:

Product (LegacyBRC) Product (RefSeq)
Orotate phosphoribosyltransferase orotate phosphoribosyltransferase
Operon # Operon
259 -
Locus Tuberculist Genome View


Locus Tag KEGG Pathways


Pyrimidine metabolism

Total items in this category:  


Metabolic pathways

Total items in this category:  
BioCyc Gene Page Cellular Overview Map
Link to STRING STRING Network


GI Number Protein ID Blast Conserved Domains
57116728 YP_177723.1 Run

orotate phosphoribosyltransferase activity

orotate phosphoribosyltransferase activity

Catalysis of the reaction: orotidine 5'-phosphate + diphosphate = orotate + 5-phospho-alpha-D-ribose 1-diphosphate.
GO Category: 
Total items in this category:  
No TFOE experiment results were found
Quantitative Proteomics Data
t-test p-value Cholesterol/Glycerol Ratio

How essentiality calculations were done?

The relative representation of each mutant was determined by calculating the fold change (sequence reads/insertion in cholesterol divided by sequence reads/insertion in glycerol) for each gene. Statistical significance was determined by t-test. Each insertion site in each replicate sample was treated as a separate data point. The hyperbola used for defining genes specifically required for growth in cholesterol was defined by the formula, y = 3.8/x+0.7. Genes above this line are annotated as required for growth on cholesterol.

TRIP log2 fold abundance change

reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.

p-value Untreated:
p-value INH: